Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Simcere and Bristol-Myers Squibb Partner on Cardiovascular Drug

publication date: Dec 14, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Simcere Pharma has signed a second drug development deal with Bristol-Myers Squibb. Simcere will complete early development work on a potential cardiovascular drug at its own expense, and in return, Simcere will gain China rights to the molecule. BMS-795311 represents the second partnership for the two companies. More details....

Stock Symbols: (NYSE: SCR) (NYSE: BMY)

Share this with colleagues:  



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners